Published 09/27/2024 6:00:00 a.m.

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

Summary by stocktitan.net

FDA approves Cobenfy for schizophrenia, marking first new mechanism in 50 years. PureTech Health receives $29M, validating its R&D model. Learn about this groundbreaking treatment and its impact.

0 Articles

All

Left

Center

Right

Medical Device News Magazine

PureTech - Invented KarXT Receives U.S. Food And Drug Administration Approval For The Treatment Of Schizophrenia In Adults - Medical Device News Magazine

Milestone triggers payments to PureTech totaling $29 million under agreements with Royalty Pharma and PureTech’s Founded Entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb in March 2024, and unlocks potential future payments related to additional milestones and royalties

09/27/2024 2:17:05 a.m.

Read Full Article

stocktitan.net

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

FDA approves Cobenfy for schizophrenia, marking first new mechanism in 50 years. PureTech Health receives $29M, validating its R&D model. Learn about this groundbreaking treatment and its impact.

09/27/2024 6:00:00 a.m.

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated09/27/2024 11:17:15 a.m.Bias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

0 Articles

0 Articles

PureTech - Invented KarXT Receives U.S. Food And Drug Administration Approval For The Treatment Of Schizophrenia In Adults - Medical Device News Magazine

PureTech - Invented KarXT Receives U.S. Food And Drug Administration Approval For The Treatment Of Schizophrenia In Adults - Medical Device News Magazine

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics